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Cancer is a devastating disease that suffered so many lives and families throughout of the world, and is becoming an increasing burden to our soci-
ety. Thanks to the advances in both basic cancer biology 
and clinical diagnostic/therapeutic treatments, cancer 
patients’ mortality has been significantly decreased in the 
past decades. Specifically, recent breakthrough in cancer 
immunology and immunotherapy has shed a bright light 
for cancer patients to guide them to fight the cancer via 
harnessing their own immune system, as some patients 
even with advanced diseases showed long-term remission 
and durable responses after immunotherapy. Although this 
new cancer treatment can only benefit a subset of cancer 
patients, it clearly suggests to us that patient’s immune 
cells have the capability to fight against cancer. It is just 
a matter of how to use them. As a peer-reviewed open 
journal, the Journal of Oncology Research is dedicated to 
publish most cutting edge research with a focus on how 
cancer invades our immune system and how to develop 
effective strategies to reverse this invasion. Journal of 
Oncology Research aims to discover innovative methods, 
theories and studies in Oncology by publishing original 
articles, case studies and comprehensive reviews. We 
hope that Journal of Oncology Research will become an 
important platform for our scientists to share their excit-
ing results and for our readers to seek fertile and reliable 
source of information. We will look for research in the 
following topics, but not limited: 
1. Cancer Immunology and Immunotherapy
This topic will cover new basic molecular and cellular 
mechanisms of interactions between tumor cells and im-
mune system; new therapeutic combinations to boost can-
cer immunotherapy; and new prognostic indicators.
2. Tumor-derived Exosomes
This topic will cover new findings in understanding how 
tumor-derived exosomes interact with immune system, 
tumor immunity, and tumor-associated fibroblasts.
3. Metastasis
This topic will include new findings in investigating novel 
mechanisms of cancer metastasis including how tumor 
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cells invade primary tissues, exit from circulation into 
distant organs, and promote niche formation in metastatic 
organs.
4. Microbiome and Cancer
This topic will cover the new investigations in under-
standing the role of microbiota in cancer progression and 
therapeutic outcomes.
5. Cancer Nanotechnology
This topic will include new findings in using nanotechnol-
ogy for early diagnosis, developing novel nanomedicines 
for targeting and reprogramming suppressive immune 
cells, and generating immunogenic cell death in combina-
tion with cancer immunotherapy.
6. Tumor Markers and Cancer Early Diagno-
sis
This topic will cover the identification of novel markers from 
liquid biopsy including blood-based assessment of tumor-de-
rived and non-tumor derived exosomes to identify a molecu-
lar signature that can inform the disease status of cancer.
